12 of them still cover a GLP-1 for obesity: Connecticut, Delaware, Kansas, Maine, Maryland, Minnesota, Mississippi, Missouri, New Hampshire, Oregon, Rhode Island, Wisconsin
Muscle Loss : Not all weight loss is beneficialsome studies indicate that lean body mass (muscle) can be lost too, potentially resulting in a lower metabolism and making maintenance challenging
They are not for human use , consumption, or therapeutic applications
The guide on why you are not losing weight on semaglutide systematically addresses each possibility
We still do not understand the link between the disease and the genes that indicate relative susceptibility to, or protection from, complications
This treatment is specifically for adults with obesity-related sleep apnea. Also, for optimal results, patients who are prescribed GLP-1s still need to combine the therapy with lifestyle changes like regular exercise and healthy eating